All fields

Brain-Computer Interfaces

How close are implanted brain interfaces to real-world use?

Live Updated 2026-04

Distance to goal

The single most intuitive view — current position against the end goal, on a log scale.

Humans implanted

Metric detail
now
5
Synchron
goal
~0.0 orders of magnitude to go

Headline indicators

Who leads

Standings by actor, within this field only.

People implanted

Metric detail
Synchron10 recipients (2025)10
Neuralink5 recipients (2025)5
Paradromicsfirst human, 20-min test (2025)1

Electrodes

Metric detail
NeuralinkN1, 64 threads1,024
Precision NeuroscienceLayer 7, FDA-cleared1,024
ParadromicsConnexus421
SynchronStentrode, vascular16

Private funding

Metric detail
Neuralink$9B valuation (2025)$1.3B
Synchron$200M Series D (2025)$0.33B
ParadromicsNEOM-led round (2025)$0.11B

Milestone timeline

Clear-cut events: crossed or not crossed.

9 achieved 0 in progress 1 locked

First human cortical implant for control

2004
BrainGate

A paralyzed person controlled a cursor via a 96-channel Utah array — the field's proof of concept.

First Neuralink human implant

2024-01
Neuralink

Noland Arbaugh received the 1,024-electrode N1; weeks later he moved a cursor and played chess by thought.

First FDA clearance for a next-gen BCI array

2025-04
Precision Neuroscience

The Layer 7 cortical interface (1,024 electrodes) got 510(k) clearance — a regulatory first for the new wave.

First native BCI–consumer device link

2025-05
Synchron / Apple

Synchron users gained native thought-control of iPhone, iPad and Vision Pro via Apple's BCI HID profile.

Third company implants a human BCI

2025-05
Paradromics

Paradromics recorded from its Connexus BCI in a human during a 20-minute procedure, widening the race.

BCI startup hits $9B valuation

2025-06
Neuralink

A $650M Series E valued Neuralink at a reported $9B, with five patients implanted.

$230M Series C for first vision-restoring BCI

2026-03
Science Corporation

Science closed an oversubscribed $230M Series C (total ~$490M) to commercialize PRIMA — a retinal BCI that restored form vision in dry-AMD patients (NEJM-published). A European launch later this year would make it the first BCI vision product on the market.

First BCI implanted in higher-level cortex

2026-04
CU Anschutz · Caltech · USC

Surgeons at CU Anschutz/UCHealth implanted a BCI into a paralyzed patient's higher-functioning cortex — not the usual motor cortex — a world first, aiming for more natural and complete sensory-and-motor control. Part of a Caltech/USC consortium using a Blackrock Neurotech array.

World's first commercial invasive-BCI approval

2026-03
Neuracle / NMPA (China)

China's NMPA cleared Neuracle's coin-sized NEO implant (developed with Tsinghua) for commercial sale to restore hand function after spinal-cord injury — the first invasive-class BCI approved for market anywhere, ahead of Neuralink.

First FDA-approved commercial BCI

~ 2030s

A brain implant cleared for routine commercial use, not just investigational trials — not yet here.

Related news & analysis

i

Every figure links to a primary source. We publish no invented scores. Tracker numbers are neutral; analysis is labelled separately.